Does aging weaken neuronal proteostasis, mitochondrial quality control, and repair capacity?

Aging is associated with reduced neuronal capacity to maintain proteins, mitochondria, and genomic integrity, creating conditions that favor protein aggregation and synaptic dysfunction. The overall relationship is biologically coherent and moderately supported, with the strongest evidence for proteostasis and mitochondrial-quality-control decline.

Clinical and neuropathological evidence

• Neuronal proteostasis declines with age through reduced chaperone activity, ubiquitin–proteasome function, and autophagy–lysosomal clearance. This diminishes refolding and removal of damaged proteins, increasing susceptibility to amyloid-β and hyperphosphorylated-tau accumulation.
• Human brain observations link aging to reduced autophagic/mitophagic capacity and accumulation of damaged mitochondria. In postmortem hippocampus from people with Alzheimer disease, basal mitophagy was reported to be approximately 30–50% lower than in matched cognitively normal individuals, with disrupted mitophagy signaling and mitochondrial abnormalities.
• These findings establish vulnerability rather than a deterministic outcome: age-related cellular changes may facilitate neurodegenerative pathology but do not alone establish disease onset or progression.

Mechanistic basis

• Defective mitochondrial turnover leaves dysfunctional mitochondria that generate excess reactive oxygen species and provide less ATP. This can impair energy-dependent protein-quality-control pathways, favoring Aβ and tau aggregation.
• Mitochondrial dysfunction also compromises calcium buffering, axonal mitochondrial trafficking, redox balance, neurotransmission, and synaptic maintenance—mechanisms directly linking mitochondrial quality-control failure to synaptic vulnerability.
• Declining nuclear and mitochondrial DNA repair in postmitotic neurons is a plausible additional route: accumulated damage may amplify oxidative stress and energy failure, disrupting synaptic signaling and integrity.

Interpretation

• Much of the human evidence is observational, and mechanistic causality is supported largely by experimental systems. Consequently, mitochondrial abnormalities and impaired repair may be both contributors to, and consequences of, established neurodegenerative pathology.

Bottom line

• Aging-related loss of proteostasis and mitochondrial quality control is supported as an important contributor to vulnerability to misfolded-protein accumulation and synaptic dysfunction; impaired neuronal repair is a credible, but less directly established, contributor to synaptic loss.